within Pharmacolibrary.Drugs.C_CardiovascularSystem.C10A_LipidModifyingAgentsPlain.C10AD06_Acipimox;

model Acipimox
  extends Pharmacolibrary.Drugs.ATC.C.C10AD06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C10AD06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Acipimox is a lipid-lowering agent belonging to the niacin derivative group, used primarily for the treatment of hyperlipidemia and hypertriglyceridemia. It reduces triglyceride and cholesterol levels by inhibiting lipolysis and is still approved and in use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics parameters reported in healthy adult volunteers after single oral dose.</p><h4>References</h4><ol><li><p>Efthymiopoulos, C, et al., &amp; Musatti, L (1993). Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers. <i>Therapie</i> 48(1) 23–26. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8356541/&quot;>https://pubmed.ncbi.nlm.nih.gov/8356541</a></p></li><li><p>Yang, XG, et al., &amp; Pan, WS (2005). [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs]. <i>Yao xue xue bao = Acta pharmaceutica Sinica</i> 40(5) 457–461. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16220793/&quot;>https://pubmed.ncbi.nlm.nih.gov/16220793</a></p></li><li><p>Schröder, O, et al., &amp; Baum, RP (1998). Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results. <i>Nuclear medicine communications</i> 19(9) 867–874. DOI:<a href=&quot;https://doi.org/10.1097/00006231-199809000-00007&quot;>10.1097/00006231-199809000-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10581593/&quot;>https://pubmed.ncbi.nlm.nih.gov/10581593</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Acipimox;
